Primary study end points occurred at week 40 (SURPASS-1, -2, and -5) or week 52 (SURPASS-3, -4, Japan-Mono, and Japan-Combo)
Peptide therapy may be considered for patients who are looking for support with: Recovery from musculoskeletal stress Soft tissue healing Skin and tissue rejuvenation Performance recovery Active aging and wellness optimization Cellular support as part of a broader regenerative strategy If you are an active adult, athlete, wellness-focused patient, or someone looking for non-surgical options to support recovery and vitality, the GLOW Protocol may be worth discussing with our medical team
Nothing else can be taken by mouth for at least 30 minutes to allow the medication to be absorbed into the bloodstream, says John Buse, an endocrinologist at the University of North Carolina at Chapel Hill, who is a consultant and investigator for Novo Nordisk
People who treat GLP-1 therapy as a window of opportunity, using the appetite suppression to build better habits rather than just eating less of the same foods, are the ones who maintain their results when the medication dose decreases or stops
If that lawsuit were to succeed, or if Novo Nordisks capacity to produce were to falter, the drugs may end up back on the shortage list
Pricing structures reflect economies of scale while maintaining competitive positioning across global markets